Introduction with Cynvenio’s Clinical Advisory
مرة 1,009 شوهد
وصف الفيديو:
Powered by LiquidBiopsy, ClearID provides a minimally-invasive tool to monitor cancer patients, enabling more frequent testing and real-time molecular profiling of tumor DNA. Leveraging patented cell enrichment technology, the test analyzes patients' individual mutations to match them with targeted cancer therapies and clinical trials.
تمت الإضافة
15 أبريل 2017
التعليقات
